Viveve Medical, Inc. - stock earnings
VIVE Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 7, 2024 AfterMarket | - / - | - | - / 1.8 million | - |
VIVE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | -5.0 million USD | 1.7 million USD |
| 2022Q2 | -5.8 million USD | 1.8 million USD |
| 2022Q1 | -5.9 million USD | 1.6 million USD |
| 2021Q4 | -6.3 million USD | 1.7 million USD |
| 2021Q3 | -5.9 million USD | 1.6 million USD |
| 2021Q2 | -4.1 million USD | 1.7 million USD |
| 2021Q1 | -5.8 million USD | 1.5 million USD |
| 2020Q4 | -4.8 million USD | 1.9 million USD |
| 2020Q3 | -3.7 million USD | 1.5 million USD |
| 2020Q2 | -7.1 million USD | 704000 USD |
VIVE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -22.0 million USD | 6.4 million USD |
| 2020 | -21.9 million USD | 5.5 million USD |
| 2019 | -42.5 million USD | 6.6 million USD |
| 2018 | -50.0 million USD | 18.5 million USD |
| 2017 | -37.0 million USD | 15.3 million USD |
VIVE
Price: $0.02
52 week price:
Earnings Per Share: -2.65 USD
P/E Ratio: 0.00
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Volume: 104883
Ebitda: -8.7 millionMarket Capitalization: 2145